Robert A. Bradway

Amgen Appoints S. Omar Ishrak To Board Of Directors

Retrieved on: 
Friday, July 30, 2021
Industry economics), Companies, Articles, Omar Ishrak, Amgen, Robert A. Bradway, Intel, Conejo Valley, Thousand Oaks, California, Board of directors

THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of S. Omar Ishrak to its Board of Directors, effective immediately.

Key Points: 
  • THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of S. Omar Ishrak to its Board of Directors, effective immediately.
  • Following the appointment of Dr. Ishrak, the Board will be composed of 12 directors, 11 of whom are independent.
  • "Omar is an accomplished business leader with deep experience in a fast-paced, technology-driven sector of the healthcare industry," said Robert A. Bradway, chairman and chief executive officer of Amgen.
  • Dr. Ishrak has been a director of Intel Corporation since 2017 and was named chairman of the board in January 2020.

Amgen Announces Webcast Of 2021 Second Quarter Financial Results

Retrieved on: 
Thursday, July 29, 2021
Industry economics), Life sciences, Pharmaceutical industry, Amgen, Robert A. Bradway, NASDAQ, Thousand Oaks, California

THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, August 3, 2021, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., July 29, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, August 3, 2021, after the close of the U.S. financial markets.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
  • The webcast will be archived and available for replay for at least 90 days after the event.

Amgen Announces Webcast Of 2020 Fourth Quarter And Full Year Financial Results

Retrieved on: 
Thursday, January 28, 2021
Businesspeople, Pharmaceutical industry, Amgen, Industry economics), Robert A. Bradway, Thousand Oaks, California, NASDAQ

THOUSAND OAKS, Calif., Jan. 28, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2020 financial results on Tuesday, Feb. 2, 2021, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., Jan. 28, 2021 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2020 financial results on Tuesday, Feb. 2, 2021, after the close of the U.S. financial markets.
  • The announcement will be followed by a conference call with the investment community at 5 p.m. EST.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.

Amgen Announces Webcast Of 2020 Third Quarter Financial Results

Retrieved on: 
Tuesday, October 27, 2020
Industries, Businesspeople, Amgen, Business, Robert A. Bradway

THOUSAND OAKS, Calif., Oct. 27,2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Wednesday, October 28, 2020, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., Oct. 27,2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Wednesday, October 28, 2020, after the close of the U.S. financial markets.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
  • The webcast will be archived and available for replay for at least 90 days after the event.

Amgen To Present At The 18th Annual Morgan Stanley Global Healthcare Conference

Retrieved on: 
Friday, September 11, 2020
Amgen, Industries, Life sciences, Robert A. Bradway, Business

THOUSAND OAKS, Calif., Sept. 11, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference at 11:45 a.m.

Key Points: 
  • THOUSAND OAKS, Calif., Sept. 11, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference at 11:45 a.m.
  • Robert A. Bradway, chairman and chief executive officer at Amgen will present at the conference.
  • A replay of the webcast will also be available on Amgen's website for at least 90 days following the event.
  • Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

Amgen Announces Webcast Of 2020 Second Quarter Financial Results

Retrieved on: 
Thursday, July 23, 2020
Industries, Amgen, Business, Life sciences, Robert A. Bradway, NASDAQ, Webcast

THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., July 23, 2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
  • The webcast will be archived and available for replay for at least 90 days after the event.

Amgen Appoints Amy E. Miles To Board Of Directors

Retrieved on: 
Thursday, July 23, 2020
Business, Articles, Industries, Robert A. Bradway, Amgen, Conejo Valley, Thousand Oaks, California, Board of directors, Chief executive officer

THOUSAND OAKS, Calif., July 23,2020 /PRNewswire/ -- Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020.

Key Points: 
  • THOUSAND OAKS, Calif., July 23,2020 /PRNewswire/ -- Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020.
  • Miles, the Board willbe composed of12 directors, 11 of whom are independent.
  • "Amy is an accomplished business leader and an experienced public company board member," said Robert A. Bradway, chairman and chief executive office of Amgen.
  • "We are confident that she will add great value to Amgen and our Board of Directors."

Amgen Announces Webcast Of 2020 First Quarter Financial Results

Retrieved on: 
Monday, April 27, 2020
Industries, Amgen, Economy of the United States, Life sciences, Robert A. Bradway, NASDAQ, Thousand Oaks, California

THOUSAND OAKS, Calif., April 27, 2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Thursday, April 30, 2020, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., April 27, 2020 /PRNewswire/ --Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Thursday, April 30, 2020, after the close of the U.S. financial markets.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.
  • The webcast will be archived and available for replay for at least 90 days after the event.

Amgen Announces Webcast Of 2019 Fourth Quarter And Full Year Financial Results

Retrieved on: 
Monday, January 27, 2020
Industries, Amgen, Economy of the United States, Life sciences, Robert A. Bradway, NASDAQ, Thousand Oaks, California

THOUSAND OAKS, Calif., Jan. 27, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2019 financial results on Thursday, Jan. 30, 2020, after the close of the U.S. financial markets.

Key Points: 
  • THOUSAND OAKS, Calif., Jan. 27, 2020 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2019 financial results on Thursday, Jan. 30, 2020, after the close of the U.S. financial markets.
  • The announcement will be followed by a conference call with the investment community at 2 p.m. PT.
  • Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
  • Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar.

Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences

Retrieved on: 
Wednesday, January 22, 2020
Businesspeople, Industries, Robert A. Bradway, Amgen, Life sciences

"Everyone needs science, and science needs everyone," said Robert A. Bradway, chairman and chief executive officer at Amgen.

Key Points: 
  • "Everyone needs science, and science needs everyone," said Robert A. Bradway, chairman and chief executive officer at Amgen.
  • LabXchange builds upon other Amgen Foundation programs that support science education, such as the Amgen Biotech Experience and Amgen Scholars that are also at Harvard FAS and institutions around the world.
  • The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work.
  • The Amgen Foundation brings the excitement of discovery to the scientists of tomorrow through several signature programs, including Amgen Scholars and the Amgen Biotech Experience.